Cherenkov luminescence imaging

From HandWiki

Cherenkov luminescence imaging (CLI) is an emerging imaging modality,[1] similar to bioluminescence imaging, that captures visible photons emitted by Cherenkov radiation. It basically is the optical imaging of radiotracers that emit charged particles traveling faster than the phase velocity of light in that particular medium. It can be used to quickly evaluate radio tracers in preclinical research[2][3][4] but also to obtain clinical images in patients.[5] While radioactivity itself can not be modified, the emitted light provides an opportunity to generate radioactivity-based activatable or "smart" imaging agents that sense for example enzymatic activity.[6]

References

  1. Ciarrocchi, Esther; Belcari, Nicola (2017). "Cerenkov luminescence imaging: physics principles and potential applications in biomedical sciences" (in en). EJNMMI Physics 4 (1): 14. doi:10.1186/s40658-017-0181-8. ISSN 2197-7364. PMID 28283990. 
  2. Ruggiero, A; Holland, J. P.; Lewis, J. S.; Grimm, J (2010). "Cerenkov luminescence imaging of medical isotopes". Journal of Nuclear Medicine 51 (7): 1123–1130. doi:10.2967/jnumed.110.076521. PMID 20554722. 
  3. Zhong, J.; Qin, C.; Yang, X.; Zhu, S.; Zhang, X.; Tian, J (2011). "Cerenkov luminescence tomography for in vivo radiopharmaceutical imaging". International Journal of Biomedical Imaging 2011 (641618): 1–6. doi:10.1155/2011/641618. PMID 21747821. 
  4. Desvaux, E.; Courteau, A.; Bellaye, PS.; Guillemin, M.; Drouet, C.; Walker, P.; Collin, B.; Decreau, R. A. (2018). "Cherenkov luminescence imaging is a fast and relevant preclinical tool to assess tumour hypoxia in vivo". EJNMMI Research 8 (1): 1–6. doi:10.1186/s13550-018-0464-7. PMID 30574662. 
  5. Thorek, D. L.; Riedl, C. C.; Grimm, J (2013). "Clinical Cerenkov Luminescence Imaging of 18F-FDG". Journal of Nuclear Medicine 55 (1): 95–98. doi:10.2967/jnumed.113.127266. PMID 24078721. 
  6. Thorek, Daniel L J; Ogirala, Anuja; Beattie, Bradley J; Grimm, Jan (2013). "Quantitative imaging of disease signatures through radioactive decay signal conversion". Nature Medicine 19 (10): 1345–50. doi:10.1038/nm.3323. PMID 24013701. 

External links